Key result
Overexpression of slow skeletal troponin I in cardiomyocytes increased proliferation and cardiac regenerative capacity following myocardial infarction in mice compared to controls.
Why the study?
It remains unclear whether an interplay exists between sarcomere isoform switching, cardiac metabolism, and cardiac regeneration during post-natal development.
Overexpression of slow skeletal troponin I in post-natal cardiomyocytes promotes a metabolic shift towards glycolysis and enhances cardiac regeneration after myocardial infarction in a mouse model.
No immediate clinical implications; leaves open troponin I modulation for post-MI regeneration in humans.
AIMS: Adult mammalian cardiomyocytes (CMs) have limited regenerative potential, and after myocardial infarction (MI), injured cardiac tissue is replaced with fibrotic scar. In contrast, the neonatal mouse heart possesses a regenerative capacity governed by CM proliferation; however, a metabolic switch from glycolysis to fatty acid oxidation during post-natal development results in loss of this regenerative capacity. Interestingly, a sarcomere isoform switch also takes place during post-natal development where slow skeletal troponin I (ssTnI) is replaced with cardiac troponin I (cTnI). It remains unclear whether there is an interplay between sarcomere isoform switching, cardiac metabolism, and regeneration. METHODS AND RESULTS: In this study, we employ proteomics, metabolomics, and lipidomics, transgenic mice, MI models, and histological analysis to delineate the molecular and sarcomeric transitions that occur during cardiac maturation and regeneration. First, we utilize integrated quantitative bottom-up and top-down proteomics to comprehensively define the proteomic and sarcomeric landscape during post-natal heart maturation. By employing a CM-specific ssTnI transgenic mouse model, we discovered that ssTnI overexpression increased CM proliferation and the cardiac regenerative capacity of the post-natal heart following MI compared to control mice by histological analysis. Our global proteomic analysis of ssTnI transgenic mice following MI reveals that ssTnI overexpression induces a significant shift in the cardiac proteomic landscape. Additionally, our lipidomic analysis demonstrated a significant up-regulation of lipid species in the transgenic mice. This proteomic shift is characterized by an up-regulation of key proteins involved in glycolytic metabolism. CONCLUSION: Collectively, our data suggest that the post-natal TnI isoform switch may play a role in the metabolic shift from glycolysis to fatty acid oxidation during post-natal maturation. This underscores the significance of a sarcomere-metabolism axis during CM proliferation and heart regeneration.
No takes yet. Share an insight, caveat, or question.
Aballo et al. (2025) studied Myocardial infarction. CM-specific ssTnI overexpression vs. control mice was evaluated on CM proliferation and cardiac regenerative capacity following MI. Overexpression of slow skeletal troponin I in cardiomyocytes increased proliferation and cardiac regenerative capacity following myocardial infarction in mice compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: